Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life.
about
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.Autologous hematopoietic cell transplantation in multiple sclerosis.Glioblastoma in natalizumab-treated multiple sclerosis patients.Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications.Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy.Identification of Peptide Mimotope Ligands for Natalizumab
P2860
Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term safety and efficacy ...... is: impact on quality of life.
@en
Long-term safety and efficacy ...... is: impact on quality of life.
@nl
type
label
Long-term safety and efficacy ...... is: impact on quality of life.
@en
Long-term safety and efficacy ...... is: impact on quality of life.
@nl
prefLabel
Long-term safety and efficacy ...... is: impact on quality of life.
@en
Long-term safety and efficacy ...... is: impact on quality of life.
@nl
P2093
P2860
P50
P921
P356
P1476
Long-term safety and efficacy ...... sis: impact on quality of life
@en
P2093
Mireia Sospedra
Raquel Planas
Roland Martin
P2860
P356
10.2147/PROM.S41768
P577
2014-04-04T00:00:00Z